Today had to be one of the slowest days so far this year…borrrring…zzzzzzz….

• Watson Pharmaceuticals buys Arrow Group for $1.75 billion. [New York Times]

• Xanodyne gets FDA approval for Zipsor (diclofenac potassium) liquid filled capsules. [Pharmalive]

• Hey! Clavis Pharma is back! [ClinicaSpace]

• Biosimilars not so easy, says WSJ. [WSJ]

• Phil Frost’s OPKO doesn’t stop. [Miami Herald]

• Finally, Teva is also ready to make some big buys, on acquisition hunt!!! [Bloomberg]

Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com

Related Posts